TruScreen Group Ltd. engages in the development, manufacture, and sale of cancer detection device and systems. It offers Truscreen Cervical Cancer screening system, which is designed to detect the presence in real time of pre-cancerous and cancerous tissue on the cervix by using optical and electrical measurements of cervical tissue. The company was founded on November 6, 2013 and is headquartered in Auckland, New Zealand.